Opendata, web and dolomites

LIGHT4LUNGS SIGNED

Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LIGHT4LUNGS project word cloud

Explore the words cloud of the LIGHT4LUNGS project. It provides you a very rough idea of what is the project "LIGHT4LUNGS" about.

departs    efficacy    bacterial    inhalable    excite    photodynamic    oxygen    morbidity    safe    self    whereby    particles    nanomedicine    reactive    paradigms    photonics    hospital    materials    science    source    respiratory    action    tests    tissue    invasive    effect    endogenous    advantage    lung    multidrug    avoiding    aerosol    profile    models    replaced    antimicrobial    patients    species    infections    tract    externally    pathogenic    lightning    light    photosensitising    fibrosis    tethers    antibiotics    photosensitiser    clinically    combined    bacteria    cytotoxic    drug    treatment    light4lungs    encompasses    chronic    free    internal    host    local    scheme    medicine    cystic    sources    persistent    lack    toxicity    eliminated    activation    porphyrins    added    physical    definition    healthcare    expertise    iron    therapeutic    acquired    resistance    irrespective    eliminating    nanotechnology    organs    itself    extended    recalcitrant    breathable    lungs    photosensitisers    elicit    diseases    luminescence    scientific    mortality    combines   

Project "LIGHT4LUNGS" data sheet

The following table provides information about the project.

Coordinator
INSTITUT QUIMIC DE SARRIA 

Organization address
address: CALLE VIA AUGUSTA 384-394
city: Barcelona
postcode: 8017
website: www.iqs.edu

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙493˙625 €
 EC max contribution 3˙493˙625 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2023-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT QUIMIC DE SARRIA ES (Barcelona) coordinator 714˙375.00
2    UNIVERSITA DEGLI STUDI DI FIRENZE IT (Florence) participant 593˙125.00
3    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 532˙500.00
4    UNIVERSITA DEGLI STUDI DI PADOVA IT (PADOVA) participant 410˙000.00
5    FUNDACIO PRIVADA INSTITUT CATALA D'INVESTIGACIO QUIMICA ES (TARRAGONA) participant 372˙500.00
6    CARDIFF SCINTIGRAPHICS LIMITED UK (CARDIFF) participant 336˙875.00
7    SORBONNE UNIVERSITE FR (PARIS) participant 294˙250.00
8    WEDO PROJECT INTELLIGENCE MADE EASY SL ES (BARCELONA) participant 240˙000.00

Map

 Project objective

Light4lungs addresses the problem of antimicrobial resistance in the treatment of chronic lung infections, which are the leading cause of morbidity and mortality in patients with diseases such as cystic fibrosis and hospital-acquired lung infections. The goal is to develop a novel therapeutic scheme for the treatment of the infections, whereby antibiotics will be replaced by inhalable light sources that will excite bacterial endogenous photosensitisers (e.g., iron-free porphyrins), eliminating the pathogenic bacteria by the photodynamic effect (local production of cytotoxic reactive oxygen species by the combined action of light, a photosensitiser and oxygen) irrespective of its multidrug resistance profile. The treatment will be safe for the host tissue because of its lack of self-photosensitising ability. Light4Lungs departs from current paradigms: (1) bacterial infections will be treated without antibiotics, which will be replaced by breathable light sources; (2) bacteria will be eliminated without any externally-added drug, taking advantage of endogenous photosensitisers; (3) a breathable light source will be used to elicit the therapeutic action, avoiding the use of invasive physical tethers to deliver light to the lungs. The project encompasses the development of particles with persistent luminescence, the aerosol technology for activation and delivery to the lungs, and the definition of the treatment parameters through toxicity and efficacy tests in clinically relevant models of respiratory infections. The project combines several different scientific expertise from photonics to medicine. The results will be useful for patients with recalcitrant respiratory tract bacterial infections and will eventually be extended to other diseases in the lungs and in other internal organs. The impact reaches beyond antimicrobial resistance itself and will affect many other fields such as healthcare, nanomedicine, materials science and nanotechnology and lightning

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIGHT4LUNGS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIGHT4LUNGS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

ATEMPGRAD (2019)

Analysing Temperature Effects with a Mobile and Precise Gradient Device

Read More  

WiPLASH (2019)

Architecting More Than Moore – Wireless Plasticity for Heterogeneous Massive Computer Architectures

Read More  

FETFX (2019)

Stimulating effects of Future and Emerging Technologies through communication and outreach

Read More